These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11763347)
1. Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNALys3/RNA initiation complex. Freund F; Boulmé F; Michel J; Ventura M; Moreau S; Litvak S Antisense Nucleic Acid Drug Dev; 2001 Oct; 11(5):301-15. PubMed ID: 11763347 [TBL] [Abstract][Full Text] [Related]
2. Study of HIV-2 primer-template initiation complex using antisense oligonucleotides. Boulmé F; Freund F; Gryaznov S; Nielsen PE; Tarrago-Litvak L; Litvak S Eur J Biochem; 2000 May; 267(9):2803-11. PubMed ID: 10785403 [TBL] [Abstract][Full Text] [Related]
3. A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome. Beerens N; Klaver B; Berkhout B J Virol; 2000 Mar; 74(5):2227-38. PubMed ID: 10666253 [TBL] [Abstract][Full Text] [Related]
4. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription. Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580 [TBL] [Abstract][Full Text] [Related]
5. HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements. Reyes-Darias JA; Sánchez-Luque FJ; Berzal-Herranz A Virus Res; 2012 Oct; 169(1):63-71. PubMed ID: 22820401 [TBL] [Abstract][Full Text] [Related]
6. In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription. Bordier B; Hélène C; Barr PJ; Litvak S; Sarih-Cottin L Nucleic Acids Res; 1992 Nov; 20(22):5999-6006. PubMed ID: 1281317 [TBL] [Abstract][Full Text] [Related]
7. Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3. Zakharova OD; Martiyanov IV; Timofeeva OA; Kolocheva TI; Fournier M; Andreola ML; Maksakova GA; Yamkovoy VI; Litvak S; Tarrago-Litvak L; Nevinsky GA Biochemistry; 1998 Sep; 37(38):13343-8. PubMed ID: 9748342 [TBL] [Abstract][Full Text] [Related]
8. Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog. Kaushik N; Talele TT; Monel R; Palumbo P; Pandey VN Nucleic Acids Res; 2001 Dec; 29(24):5099-106. PubMed ID: 11812842 [TBL] [Abstract][Full Text] [Related]
9. Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex. Freund F; Boulmé F; Litvak S; Tarrago-Litvak L Nucleic Acids Res; 2001 Jul; 29(13):2757-65. PubMed ID: 11433020 [TBL] [Abstract][Full Text] [Related]
10. Role of the primer activation signal in tRNA annealing onto the HIV-1 genome studied by single-molecule FRET microscopy. Beerens N; Jepsen MD; Nechyporuk-Zloy V; Krüger AC; Darlix JL; Kjems J; Birkedal V RNA; 2013 Apr; 19(4):517-26. PubMed ID: 23404895 [TBL] [Abstract][Full Text] [Related]
11. In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus. Seif E; Niu M; Kleiman L Retrovirology; 2015 May; 12():40. PubMed ID: 25981241 [TBL] [Abstract][Full Text] [Related]
12. Structural variability of the initiation complex of HIV-1 reverse transcription. Goldschmidt V; Paillart JC; Rigourd M; Ehresmann B; Aubertin AM; Ehresmann C; Marquet R J Biol Chem; 2004 Aug; 279(34):35923-31. PubMed ID: 15194685 [TBL] [Abstract][Full Text] [Related]
13. The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA. Cen S; Niu M; Kleiman L Retrovirology; 2004 Oct; 1():33. PubMed ID: 15494076 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex. Brulé F; Marquet R; Rong L; Wainberg MA; Roques BP; Le Grice SF; Ehresmann B; Ehresmann C RNA; 2002 Jan; 8(1):8-15. PubMed ID: 11873759 [TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2. Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587 [TBL] [Abstract][Full Text] [Related]
16. Multiple forms of tRNA(Lys3) in HIV-1. Li Z; Shalom A; Huang Y; Mak J; Arts E; Wainberg MA; Kleiman L Biochem Biophys Res Commun; 1996 Oct; 227(2):530-40. PubMed ID: 8878548 [TBL] [Abstract][Full Text] [Related]
17. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells. Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137 [TBL] [Abstract][Full Text] [Related]
18. Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions. Sleiman D; Goldschmidt V; Barraud P; Marquet R; Paillart JC; Tisné C Virus Res; 2012 Nov; 169(2):324-39. PubMed ID: 22721779 [TBL] [Abstract][Full Text] [Related]
19. The HIV plus-strand transfer reaction: determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence. Muthuswami R; Chen J; Burnett BP; Thimmig RL; Janjic N; McHenry CS J Mol Biol; 2002 Jan; 315(3):311-23. PubMed ID: 11786014 [TBL] [Abstract][Full Text] [Related]
20. Mutations within the primer binding site of the human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription. Wakefield JK; Morrow CD Virology; 1996 Jun; 220(2):290-8. PubMed ID: 8661380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]